Authors: Li Shiding, Chen Liangbo, Fu Yao Published: 2026 -06 -10 DOI: 10.3760/cma.j.cn115989-20230601-00206 Citation Li Shiding, Chen Liangbo, Fu Yao. Progress in the treatment of corneal neovascularization with anti-VEGF drugs[J]. Chin J Exp Ophthalmol, 2026, 44(6):584-589. DOI: 10.3760/cma.j.cn115989-20230601-00206. ABSTRACT [Download PDF] [Read Full Text] The cornea is an important refractive […]
Tag: Vascular endothelial growth factor
Application progress of gene therapy targeting vascular endothelial growth factor in ocular fundus vascular diseases
Authors: Bao Yanbo, Xie Zhenggao Published: 2026 -06 -10 DOI: 10.3760/cma.j.cn115989-20250709-00226 Citation Bao Yanbo, Xie Zhenggao. Application progress of gene therapy targeting vascular endothelial growth factor in ocular fundus vascular diseases[J]. Chin J Exp Ophthalmol, 2026, 44(6):590-598. DOI: 10.3760/cma.j.cn115989-20250709-00226. ABSTRACT [Download PDF] [Read Full Text] The pathogenesis of ocular vascular […]
Construction of a machine learning-guided prediction model for the efficacy of anti-VEGF treatment in diabetic macular edema
Authors: Cui Haoqiang, Xiao Kunhong, Lu Wenrui, Huang Yan, Li Li DOI: 10.3760/cma.j.cn115989-20250608-00186 Published: 2025 -11 -10 Citation Cui Haoqiang, Xiao Kunhong, Lu Wenrui, et al. Construction of a machine learning-guided prediction model for the efficacy of anti-VEGF treatment in diabetic macular edema[J]. Chin J Exp Ophthalmol, 2025, 43(11):1024-1034. DOI: 10.3760/cma.j.cn115989-20250608-00186. ABSTRACT […]
Research progress in reactivation factors and prevention of retinopathy of prematurity after anti-VEGF therapy
Authors: Zhong Yusheng, Liang Jianhong, Li Xiaoxin, Cheng Yong DOI: 10.3760/cma.j.cn115989-20211116-00633 Published: 2025 -08 -10 Citation Zhong Yusheng, Liang Jianhong, Li Xiaoxin, et al. Research progress in reactivation factors and prevention of retinopathy of prematurity after anti-VEGF therapy[J]. Chin J Exp Ophthalmol, 2025, 43(8):761-765. DOI: 10.3760/cma.j.cn115989-20211116-00633. ABSTRACT [Download PDF] […]
Research status of different doses of anti-vascular endothelial growth factor drugs in retinopathy of prematurity
Authors: Jiang Keke, Zhang Jie DOI: 10.3760/cma.j.cn115989-20200809-00573 Published 2024-07-10 Cite as Chin J Exp Ophthalmol, 2024, 42(7): 669-674. Abstract 【Download PDF】【Read Full Text】 With the further study of vascular endothelial growth factor (VEGF) in the pathogenesis of retinopathy of prematurity (ROP), a variety […]
Effect and significance of secretogranin Ⅲ in diabetic retinal neovascularization
Authors: Wang Manqiao, Li Xiaorong DOI: 10.3760/cma.j.cn115989-20201012-00688 Published 2024-01-10 Cite as Chin J Exp Ophthalmol, 2024, 42(1): 93-96. Abstract [Download PDF] [Read Full Text] Secretogranin Ⅲ (SCG3) is a kind of secretory granule widely distributed in tissues and cells with endocrine functions […]
Advances in anti-VEGF/VEGFR targeting drugs for corneal neovascularization
Authors: Wang Qun, Huang Yifei DOI: 10.3760/cma.j.issn.2095-0160.2015.12.018 Published 2015-12-10 Cite as Chin J Exp Ophthalmol, 2015,33(12): 1138-1143. Abstract [Download PDF] [Read Full Text] Cornea is an important part of the refractive media.Healthy cornea is clear and avascular.Corneal avascularity is necessary for the […]
Current advance in the application of Alfibercept in ophthalmology
Authors: Chen Xi, Xie Zhenggao DOI: 10.3760/cma.j.issn.2095-0160.2015.12.019 Published 2015-12-10 Cite as Chin J Exp Ophthalmol, 2015,33(12): 1144-1147. Abstract [Download PDF] [Read Full Text] As the newest anti-vascular endothelial grown factor (VEGF) drug, alfibercept binds to all forms of VEGF-A, VEGF-B, and PIGF.So […]
Critical guiding role of OCT angiography in long-term treatment and follow-up of neovascular AMD
Authors: Bo Qiyu, Sun Xiaodong DOI: 10.3760/cma.j.cn115989-20220617-00282 Published 2022-07-10 Cite asChin J Exp Ophthalmol, 2022, 40(7): 604-608. Abstract [View PDF] [Read Full Text] The pathogenesis of neovascular age-related macular degeneration (nAMD) is complex and macular neovascularization (MNV), a key pathogenic factor in […]
Effect of anti-VEGF intravitreal injections on the development of nervous system in retinopathy of prematurity
Authors: Tian Ya, Zhang Fuyan, Zhang Guoming DOI: 10.3760/cma.j.cn115989-20200731-00548 Published 2022-03-10 Cite asChin J Exp Ophthalmol, 2022, 40(3): 271-275. Abstract [View PDF] [Read Full Text] Retinopathy of prematurity (ROP) is a blinding eye disease characterized by abnormal proliferation of retinal blood vessels in children.Vascular endothelial […]